Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.

Unson CG, Cypess AM, Wu CR, Goldsmith PK, Merrifield RB, Sakmar TP.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):310-5.

2.
3.

Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.

Unson CG, Wu CR, Jiang Y, Yoo B, Cheung C, Sakmar TP, Merrifield RB.

Biochemistry. 2002 Oct 1;41(39):11795-803.

PMID:
12269822
5.

The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.

Lins L, Couvineau A, Rouyer-Fessard C, Nicole P, Maoret JJ, Benhamed M, Brasseur R, Thomas A, Laburthe M.

J Biol Chem. 2001 Mar 30;276(13):10153-60. Epub 2000 Dec 21.

7.

Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.

Myers DA, Trinh JV, Myers TR.

Mol Cell Endocrinol. 1998 Sep 25;144(1-2):21-35.

PMID:
9863624
8.

Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.

Krstenansky JL, Trivedi D, Hruby VJ.

Biochemistry. 1986 Jul 1;25(13):3833-9.

PMID:
3017406
9.
10.
11.

The role of histidine-1 in glucagon action.

Unson CG, Macdonald D, Merrifield RB.

Arch Biochem Biophys. 1993 Feb 1;300(2):747-50.

PMID:
8382034
12.

Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.

Johns TG, Adams TE, Cochran JR, Hall NE, Hoyne PA, Olsen MJ, Kim YS, Rothacker J, Nice EC, Walker F, Ritter G, Jungbluth AA, Old LJ, Ward CW, Burgess AW, Wittrup KD, Scott AM.

J Biol Chem. 2004 Jul 16;279(29):30375-84. Epub 2004 Apr 9.

16.

Glucagon: structure-function relationships investigated by sequence deletions.

Frandsen EK, Grønvald FC, Heding LG, Johansen NL, Lundt BF, Moody AJ, Markussen J, Vølund A.

Hoppe Seylers Z Physiol Chem. 1981 Jun;362(6):665-77.

PMID:
6268519
17.

Lack of glucagon receptors in Morris hepatoma 7800.

Mourelle M, Rojkind M.

Hepatology. 1984 May-Jun;4(3):515-9.

PMID:
6327489
18.

Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor.

Mendre C, Dufour MN, Le Roux S, Seyer R, Guillou L, Calas B, Guillon G.

J Biol Chem. 1997 Aug 22;272(34):21027-36.

19.

Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).

Frandsen EK, Thim L, Moody AJ, Markussen J.

J Biol Chem. 1985 Jun 25;260(12):7581-4.

20.

Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor.

Zvirblienë A, Zvirblis G, Cao YJ, Fahrenholz F.

Hybridoma. 1999 Aug;18(4):335-42.

PMID:
10571263

Supplemental Content

Support Center